TheStreet’s Jim Cramer answered questions from social media on the floor of the New York Stock Exchange. One viewer asked if they should stay the course or take a loss on Skechers (SKX), which saw shares slump almost 40 percent over the past month. ‘I think long-term, Sketchers is good, but understand, they sell into a place like Macy’s (M),’ Cramer said. ‘You have to deal with the fact that there’s not a lot of mall traffic because it’s just too warm.’ Speaking of Macy’s, another viewer asked about the competence of Macy’s CEO Terry Lundgren. The retail giant’s same store sales dropped 3.6 percent during the third quarter. ‘I think Terry is very good,’ Cramer said. ‘They have a flagship store that’s in New York that’s being hurt by a strong dollar and I think people are using Macy’s as a showroom for Amazon (AMZN).’ Sticking with retail, another viewer wanted Cramer’s take on Whole Foods (WFM), a stock that’s lost 41 percent since the start of the year. ‘I have been very adamant that Whole Foods is not at a bottom yet,’ Cramer added. ‘I know a lot of people think that because of the buyback that it’s the right time to buy. I like to buy stocks that have positive earnings momentum or growth and Whole Foods doesn’t have that right now.’ On the flip side, Cramer said Kroger (KR) is his favorite retailer in the supermarket space. Send your questions to Jim Cramer on Facebook and Twitter @Jim Cramer, using #CramerQ.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.